Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TDP2 | O95551 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27931079 | 0.90 | ALDH1A1 (0.44) | ALDH1A1TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL19995979 | 0.90 | ALDH1A1 (0.33) | ALDH1A1TDP2NSD2HSP90AA1PAX8 | |
| Phenol SCHEMBL28205640 | 0.82 | TDP1 (0.44) | ALDH1A1TDP1CYP3A4CYP1A2 | |
| SCHEMBL30663464 | 0.81 | ALDH1A1 (0.41) | ALDH1A1POLBTDP1 | |
| SCHEMBL1023210 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TDP2NSD2HSP90AA1PAX8 | |
| Phenol SCHEMBL28290726 | 0.78 | CA12 (0.39) | ALDH1A1HSP90AA1TDP1CYP3A4TSHR | |
| SCHEMBL30238695 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TDP2POLBTDP1CYP3A4 | |
| SCHEMBL29863836 | 0.78 | POLB (0.56) | ALDH1A1POLBTDP1CASP1CYP3A4 | |
| SCHEMBL1198842 | 0.78 | POLB (0.56) | ALDH1A1POLBTDP1CASP1CYP3A4 | |
| SCHEMBL29380074 | 0.77 | ALDH1A1 (0.42) | ALDH1A1HSP90AA1TDP1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124649-A1 | CAPPED BISPHENOL POLYETHER OLIGOMER AND COMPOSITION, METHOD OF MANUFACTURE, AND ARTICLES MADE THEREFROM | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2024-04-18 | — | — | US | disclosed |
| US-8263798-B2 | Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same | NAGASE & CO., LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8252952-B2 | Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same | NAGASE & CO., LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20120108846-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20120101309-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120101310-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120095252-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20120095218-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
| US-7582691-B2 | Poly(arylene ether) compositions and articles | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-09-01 | — | — | US | disclosed |
| US-20080171817-A1 | POLY(ARYLENE ETHER) COMPOSITIONS AND ARTICLES | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108846-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | ALDH1A1 3013/4885TDP2 4255/4885NSD2 3584/4885 |
| US-20120101309-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | ALDH1A1 3108/4885TDP2 3729/4885NSD2 3475/4885 |
| US-20120095252-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | ALDH1A1 3013/4885TDP2 4255/4885NSD2 3584/4885 |
| US-20120095218-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | ALDH1A1 3013/4885TDP2 4255/4885NSD2 3584/4885 |
| US-20120101310-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | ALDH1A1 3013/4885TDP2 4255/4885NSD2 3584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.